Dinoges EV is categorized as antiandrogenic gestagen effective in reducing and alleviating the anxiety of menopausal symptoms. Dinoges EV is a Hormone Replacement Therapy (HRT). It contains two types of female hormones, an oestrogen and a progestogen. Dinoges EV is used in postmenopausal women with at least 12 months since their last natural period and who still have their uterus.

Zoleta tablet is the preparation of 2.5mg Letrozole which is a nonsteroidal selective aromatase inhibitor and hence an antiestrogen. Zoleta (Letrozole) prevents aromatase from producing estrogens by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of corticosteroids. Therefore, Androgen conversion to Estrogen (through aromatization process) is Inhibited. This results in decreased amount of Estrogen.

Caprogen DS is the preparation of Hydroxyprogesterone Caproate 500mg/2ml. Caprogen is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth. The effectiveness of Caprogen is based on improvement in the proportion of women who delivered <37 weeks of gestation.

Liana is a combination of Drospirenone, a progestin, and Estetrol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy & cycle control.

Dydrogesterone is an orally active progestogen which acts directly on the uterus, producing a complete secretory endometrium in an estrogen-primed uterus. At therapeutic levels, Dydrogesterone has no contraceptive effect as it does not inhibit or interfere with ovulation or the corpus luteum.